Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11922164 | 1.00 | MAPK1 (0.31) | MAPK1HRH3 | |
| SCHEMBL11922156 | 1.00 | MAPK1 (0.31) | MAPK1HRH3 | |
| SCHEMBL16104230 | 0.81 | — | — | |
| SCHEMBL24791183 | 0.76 | — | — | |
| SCHEMBL16316437 | 0.76 | — | — | |
| SCHEMBL20995960 | 0.75 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL28610109 | 0.75 | HRH3 (0.32) | HRH3 | |
| SCHEMBL1075261 | 0.75 | MAPK1 (0.40) | MAPK1HRH3 | |
| SCHEMBL25042721 | 0.74 | MAPK1 (0.31) | MAPK1 | |
| SCHEMBL21104589 | 0.73 | MAPK1 (0.31) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240218523-A1 | CORROSION RESISTANT COATING SYSTEMS | THE BOEING COMPANY | 2024-07-04 | — | — | US | disclosed |
| US-20240018156-A1 | SPIROCYCLIC COMPOUNDS | C4 THERAPEUTICS, INC. (US) | 2024-01-18 | — | — | US | disclosed |
| US-20230383148-A1 | NONAQUEOUS SOL-GEL FOR ADHESION ENHANCEMENT OF WATER-SENSITIVE MATERIALS | THE BOEING COMPANY | 2023-11-30 | — | — | US | disclosed |
| US-20230357595-A1 | CORROSION RESISTANT ADHESIVE SOL-GEL | THE BOEING COMPANY | 2023-11-09 | — | — | US | disclosed |
| US-20230357592-A1 | CORROSION RESISTANT ADHESIVE SOL-GEL | THE BOEING COMPANY | 2023-11-09 | — | — | US | disclosed |
| US-20230357180-A1 | DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION | C4 THERAPEUTICS, INC. (US) | 2023-11-09 | — | — | US | disclosed |
| US-20230279023-A1 | N/O-Linked Degrons and Degronimers for Protein Degradation | C4 THERAPEUTICS, INC. (US) | 2023-09-07 | — | — | US | disclosed |
| US-11746245-B2 | Soluble corrosion resistant sol-gel | THE BOEING COMPANY (US) | 2023-09-05 | — | — | US | disclosed |
| US-11739237-B2 | Nonaqueous sol-gel for adhesion enhancement of water-sensitive materials | THE BOEING COMPANY (US) | 2023-08-29 | — | — | US | disclosed |
| US-11692113-B2 | Nonaqueous sol-gel for adhesion enhancement of water-sensitive materials | THE BOEING COMPANY (US) | 2023-07-04 | — | — | US | disclosed |
| US-20180127420-A1 | CONDENSED-RING PYRIMIDYLAMINO DERIVATIVE, PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS THEREOF | GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD. (CN) | 2018-05-10 | — | — | US | disclosed |
| US-20170273970-A1 | Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders | Grünenthal GmbH (DE) | 2017-09-28 | — | — | US | disclosed |
| US-20160297823-A1 | SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME | INSTITUTE FOR DRUG DISCOVERY, LLC | 2016-10-13 | — | — | US | disclosed |
| WO-2013057267-A1 | COMPOSITION COMPRISING A NON-IONIC SURFACTANT AND AN IONIC POLYMER | ASHLAND LICENSING AND INTELLECTUAL PROPERTY LLC (US) | 2013-04-25 | — | — | WO | disclosed |
| US-8198473-B2 | Process for preparing organically modified siloxanes | EVONIK GOLDSCHMIDT GMBH (DE) | 2012-06-12 | — | — | US | disclosed |
| US-20110065196-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2011-03-17 | — | — | US | disclosed |
| US-20110065808-A1 | CARBONYL COMPOUND REMOVER | AJINOMOTO CO. INC. (JP) | 2011-03-17 | — | — | US | disclosed |
| US-20100056818-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | EVONIK GOLDSCHMIDT GMBH (DE) | 2010-03-04 | — | — | US | disclosed |
| US-7635581-B2 | Process for preparing organically modified siloxanes | GOLDSCHMIDT GMBH (DE) | 2009-12-22 | — | — | US | disclosed |
| US-20070184006-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | GOLDSCHMIDT GMBH (DE) | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018156-A1 | SPIROCYCLIC COMPOUNDS | CRBN, XIAP, RBX1 | MAPK1 3405/4885HRH3 4672/4885 |
| US-20170273970-A1 | Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders | TSPO, TPMT, HLA-DRB1 | MAPK1 3508/4885HRH3 457/4885 |
| US-20230357180-A1 | DEGRADERS AND DEGRONS FOR TARGETED PROTEIN DEGRADATION | STUB1, MDM2, USP30 | MAPK1 3828/4885HRH3 4130/4885 |
| US-20110065808-A1 | CARBONYL COMPOUND REMOVER | C1R, CBR1, CBR3 | MAPK1 1312/4885HRH3 36/4885 |
| US-20160297823-A1 | SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME | CMA1, CHIA, AADAC | MAPK1 2351/4885HRH3 30/4885 |
| US-20070184006-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | HSD17B12, CYP51A1, ESD | MAPK1 4365/4885HRH3 3419/4885 |
| US-20180127420-A1 | CONDENSED-RING PYRIMIDYLAMINO DERIVATIVE, PREPARATION METHOD THEREFOR, AND INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND APPLICATIONS THEREOF | PDK1, WEE1, DCK | MAPK1 1033/4885HRH3 3039/4885 |
| US-20100056818-A1 | PROCESS FOR PREPARING ORGANICALLY MODIFIED SILOXANES | HSD17B12, CYP51A1, ESD | MAPK1 4365/4885HRH3 3419/4885 |
| US-20230279023-A1 | N/O-Linked Degrons and Degronimers for Protein Degradation | CRBN, CBL, STUB1 | MAPK1 4293/4885HRH3 4378/4885 |
| US-20110065196-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | PTMS, PTMA, TST | MAPK1 4219/4885HRH3 4445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.